These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

770 related articles for article (PubMed ID: 18727800)

  • 1. Resistance to fluoroquinolones by the combination of target site mutations and enhanced expression of genes for efflux pumps in Shigella flexneri and Shigella sonnei strains isolated in Korea.
    Kim JY; Kim SH; Jeon SM; Park MS; Rhie HG; Lee BK
    Clin Microbiol Infect; 2008 Aug; 14(8):760-5. PubMed ID: 18727800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of fluoroquinolone-resistant Shigella flexneri in Hangzhou area of China.
    Pu XY; Pan JC; Wang HQ; Zhang W; Huang ZC; Gu YM
    J Antimicrob Chemother; 2009 May; 63(5):917-20. PubMed ID: 19297378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluoroquinolone Resistance Mechanisms in Shigella Isolates in Shanghai, China, Between 2010 and 2015.
    Zhang WX; Chen HY; Tu LH; Xi MF; Chen M; Zhang J
    Microb Drug Resist; 2019 Mar; 25(2):212-218. PubMed ID: 30307807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluoroquinolone resistance mechanisms of Shigella flexneri isolated in Bangladesh.
    Azmi IJ; Khajanchi BK; Akter F; Hasan TN; Shahnaij M; Akter M; Banik A; Sultana H; Hossain MA; Ahmed MK; Faruque SM; Talukder KA
    PLoS One; 2014; 9(7):e102533. PubMed ID: 25028972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular characteristics of class 1 and class 2 integrons and their relationships to antibiotic resistance in clinical isolates of Shigella sonnei and Shigella flexneri.
    Pan JC; Ye R; Meng DM; Zhang W; Wang HQ; Liu KZ
    J Antimicrob Chemother; 2006 Aug; 58(2):288-96. PubMed ID: 16766536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Susceptibility of 570 Pseudomonas aeruginosa strains to 11 antimicrobial agents and the mechanism of its resistance to fluoroquinolones].
    Lei YC; Wang HB; Sun ZY; Shen ZY
    Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):403-7. PubMed ID: 12820918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wide dissemination of multidrug-resistant Shigella isolates in China.
    Zhang W; Luo Y; Li J; Lin L; Ma Y; Hu C; Jin S; Ran L; Cui S
    J Antimicrob Chemother; 2011 Nov; 66(11):2527-35. PubMed ID: 21859815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV in clinical strains of fluoroquinolone-resistant Shigella in Anhui, China.
    Hu LF; Li JB; Ye Y; Li X
    J Microbiol; 2007 Apr; 45(2):168-70. PubMed ID: 17483803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural Insights into the Fluoroquinolone Resistance Mechanism of Shigella flexneri DNA Gyrase and Topoisomerase IV.
    Tamanna ; Ramana J
    Microb Drug Resist; 2016 Jul; 22(5):404-11. PubMed ID: 26859259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The acquisition of full fluoroquinolone resistance in Salmonella Typhi by accumulation of point mutations in the topoisomerase targets.
    Turner AK; Nair S; Wain J
    J Antimicrob Chemother; 2006 Oct; 58(4):733-40. PubMed ID: 16895934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel mutations in gyrA and parC among Shigella sonnei strains from Jiangsu Province of China, 2002-2011.
    Gu B; Qin TT; Fan WT; Bi RR; Chen Y; Li Y; Ma P
    Int J Infect Dis; 2017 Jun; 59():44-49. PubMed ID: 28392317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergence of high-level fluoroquinolone resistance in emm6 Streptococcus pyogenes and in vitro resistance selection with ciprofloxacin, levofloxacin and moxifloxacin.
    Malhotra-Kumar S; Van Heirstraeten L; Lammens C; Chapelle S; Goossens H
    J Antimicrob Chemother; 2009 May; 63(5):886-94. PubMed ID: 19279051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and characterisation of plasmid-mediated quinolone resistance and mutations in the gyrase and topoisomerase IV genes among Shigella isolates from Henan, China, between 2001 and 2008.
    Yang H; Duan G; Zhu J; Zhang W; Xi Y; Fan Q
    Int J Antimicrob Agents; 2013 Aug; 42(2):173-7. PubMed ID: 23796894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fluoroquinolone resistance mutations in topoisomerase genes of Salmonella typhimurium isolates].
    Guo Y; Pei X; Liu X
    Wei Sheng Yan Jiu; 2004 Sep; 33(5):591-4. PubMed ID: 15612489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of plasmid-mediated quinolone-resistance determinants in Shigella flexneri isolates from Anhui Province, China.
    Xiong Z; Li J; Li T; Shen J; Hu F; Wang M
    J Antibiot (Tokyo); 2010 Apr; 63(4):187-9. PubMed ID: 20203702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of sitafloxacin against clinical strains of Streptococcus pneumoniae with defined amino acid substitutions in QRDRs of gyrase A and topoisomerase IV.
    Touyama M; Higa F; Nakasone C; Shinzato T; Akamine M; Haranaga S; Tateyama M; Nakasone I; Yamane N; Fujita J
    J Antimicrob Chemother; 2006 Dec; 58(6):1279-82. PubMed ID: 17056610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluoroquinolone-resistant Brucella melitensis mutants obtained in vitro.
    Lázaro FG; Rodríguez-Tarazona RE; García-Rodríguez JA; Muñoz-Bellido JL
    Int J Antimicrob Agents; 2009 Sep; 34(3):252-4. PubMed ID: 19243922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluoroquinolone resistance and gyrA and parC mutations of Escherichia coli isolated from chicken.
    Lee YJ; Cho JK; Kim KS; Tak RB; Kim AR; Kim JW; Im SK; Kim BH
    J Microbiol; 2005 Oct; 43(5):391-7. PubMed ID: 16273029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutations in gyrA & parC genes of Shigella flexneri 2a determining the fluoroquinolone resistance.
    Divya MP; Mathew PD; Jyothi R; Bai R; Thomas S
    Indian J Med Res; 2015 Jun; 141(6):836-8. PubMed ID: 26205028
    [No Abstract]   [Full Text] [Related]  

  • 20. Are fluoroquinolone-susceptible isolates of Streptococcus pneumoniae really susceptible? A comparison of resistance mechanisms in Canadian isolates from 1997 and 2003.
    Schurek KN; Adam HJ; Siemens CG; Hoban CJ; Hoban DJ; Zhanel GG
    J Antimicrob Chemother; 2005 Oct; 56(4):769-72. PubMed ID: 16126779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.